Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Etoposide|DRUG: Irinotecan hydrochloride
Sponsor: University of Arizona
Collaborators: National Cancer Institute (NCI)